Otsuka to acquire Neurovance in $100m deal

03-03-2017

Otsuka to acquire Neurovance in $100m deal

istocksdaily / iStockphoto.com

Otsuka Pharmaceutical has agreed to acquire Neurovance, a privately held clinical stage pharma company.


Otsuka, Neurovance, M&A, ADHD, acquisition, pharmaceutical, Tatsuo Higuchi,

LSIPR